secular growth stori trackaw focus new custom
growth vs pricing/margin prime revolution retail
miss user growth near-term high maintain outperform
quick read trip
expect reset time think futur
translat semin research new drug prostat
cancer initi outperform
color fundament focu call
clinic updat support continu develop aml
solid ep scale model custom renew share
consider ahead result
review focu turn busi fundament pt
sector multipl compress
analyst certif import disclosur see
result jive lastpass thrive invest
sign sale momentum encourag
 finish year solid note provid encourag outlook
strong year nbc/ski tweak estim
consensu reiter outperform pt
headwind near-term upcom catalyst
get closer inflect point
appoint former ceo amena ceo maintain
industri headwind particularli apac weigh near-term
first look result
first look oil product strong expens profil drive
revis preliminari guidanc
earn commentari point sever cross
secular growth stori trackaw focus new custom growth vs pricing/margin prime
lower target maintain outperform rate secular growth stori remain track aw deliv
disappoint revenu margin manag highlight y/i growth contract revenu would
agre cloud transit plenti runway e-commerce gross profit acceler y/i despit invest
day prime drive na revenu acceler y/i non-aw revenu segment
acceler on-line seller servic advertis revenu acceler ex fx partli aid india holiday
calendar shift guidanc impli revenu y/i vs lower margin prime roll-out given
success make invest expect investor look near-term margin pressur
darn data privaci complianc -- data opt-in bug caus price miss user growth near-term high maintain
lower target maintain outperform rate despit weaker result price management
highlight softwar glitch poor user interfac flow design captur privacy-compli user data necessari
higher-valu audienc target ad combin fewer new product/ev launch vs always-on spend benefit
fb/goog revenu street estim data-rel issu impact like earli howev
mdau increas near-record growth rate us/int y/i acceler product
enhanc better market management sound bullish impact japan summer olymp reason
cash flow valuat provid support stock assum sale ebitda
analyt collabor infrastructur softwar
follow multipl convers investor believ grow confus around alteryx key metric effort
clarifi highlight follow salesforc commiss total contract valu tcv make bill less
relev evalu busi activ tcv calcul use remain perform oblig rpo
made revenue/tcv season extrem consensu bill metric miscalcul estim dont
take account chang contract asset intern activ account revenu uk
largest countri signific confus around key metric calcul find
difficult assess real expect maintain bullish long-term view
quick read trip
mid-jul lower rate perform outperform valuat prospect limit
fundament upsid n-t speed bump ahead note weaker expect
sep result report play well cautiou nearer-term stanc share overal
continu view ceo brett ponton team take right step effect reposit look chain
still suscept variabl within macro competit backdrop auto servic await compel
evalu potenti turn construct
expect reset time think futur past
report core ep vs our/consensu cautiou sinc assum coverag
recent believ new manag would reset outlook reflect industry-compar
yoy ar growth/conservat stock reduct ytd believ share
near fulli re-rat card-onli compani price-to-earnings given reset increment posit share
hit guidanc yoy ar growth yoy nco guidanc without expect new buy-back
author downward revis like rear-view mirror stock could stabil manag articul
competit advantag marketplac expand non-legaci vertic
translat semin research new drug prostat cancer initi outperform
despit sever drug approv last decad advanc prostat cancer remain area high unmet medic need
diseas kill men per year us alon difficult control due wide rang resist
mechan render tumor insensit mainstay therapi includ androgen receptor ar antagonist
develop uniqu class ar antagonist call aniten may help overcom common resist
mechan essa lead product shown potent preclin activ highli resist tumor model
insensit standard-of-car therapi recapitul clinic could becom essenti new therapi
metastat castration-resist prostat cancer mcrpc initi outperform pt
color fundament focu call
clinic updat support continu develop aml reiter outperform
thursday syro present updat phase result esh intern confer aml syro
evalu combin azacitidin azac newli diagnos aml patient combin continu
show impress activ biomarker-defin set patient cr/cri rara cohort believ strongli
support continu develop cr/cri rate observ rara-neg patient may attribut single-
agent azac given mild safeti profil believ combin could becom prefer option rara
patient unfit standard induct chemo syro priorit develop relapsed/refractori set may offer
streamlin develop pathway initi data r/r patient expect reiter outperform pt
organ growth guidanc sales/ep ahead sale vs our/street
ep vs our/street broad-bas neurosurgeri growth better expect instrument sale
along solid pace css organ ott flat neg impact privat label
custom inventori work-down also suppli disrupt associ product steril inpati wound suppli
constraint outpati wound impact ott expect improv quarter close last
major tsa codman integr essenti complet organ sale growth ep rang
re-affirmed impli ep assum increas invest growth initi includ recent technolog
solid ep scale model custom renew share gain continu
report slight revenue miss ep beat vs strength xt pop
health solut partial off-set fx headwind brexit-rel delay higher revenu scale oper item
drove ep beat dso day day sequenti day y/i higher sale increas collect
narrow revenu ep guidanc reaffirm book dealflow includ sever va deal
world largest gpo vizient top five merci system said continu take
market share lead us believ medic platform reson well marketplac believ strong book
backlog drive continu top-line growth reiter outperform
consider ahead result
review sever key consider ahead result includ financi outlook
revenu estim slightli consensu recent otezla acquisit enbrel
patent legal victori bolster auto-immun portfolio kra inhibitor file strategi earli nsclc
data repatha price aimovig launch trajectori biosimilar capit alloc recent met
manag expect continu industri consolid reinforc optim around upcom catalyst
bullish stanc base long-term stabl revenu forecast oper margin expans updat model
script adjust maintain outperform pt detail full report date
review focu turn busi fundament pt sector multipl compress
gilead report sales/earn provid investor updat quarter line
consensu estim miss opco expect see top line bottom line due one-off
hiv/hcv franchis compani still manag opex smartli continu trend maintain adjust oper
margin new manag cfo/cmo slot expect updat commerci execut pipelin
hiv continu strong hcv stabil yescarta still surpris quarterli variat filgotinib file
timelin us/ex-u file firm adjust number go forward trim pt
due sector multipl compress stay bullish
result jive lastpass thrive invest revit gotomeet platform
print solid revenu ebitda ep exceed guidanc annual outlook up slightli
profit front adjust ebitda ep revenu guidanc held steadi y/i mid-
point takeaway quarter includ result track accord strateg plan revenu gener
growth segment inflect posit anoth sequenti yoy growth product shine
quarter driven lastpass y/i jive gotoconnect product y/i invest made overhaul
lag core gotomeet platform current drive perform encourag healthi
perform growth product await improv core busi perform
exceed estim across board up outlook addit compani provid
preliminari guidanc call y/i revenu growth view posit current environ moreov
manag indic see econom moder global basi think valid mission critic
natur broader email arena near-term driver includ cloud migrat healthi demand cloud-
base revenu y/i legaci displac on-premis incumb high-end enterpris grow archiv
need propel larg deal size recent quarter recent partnership crowdstrik support
horizont vertic expans applaud consist execut maintain perform rate given recent run
report solid result y/i revenu growth exceed estim said
expect somewhat upsid given signific quarterli mortgag market tailwind also adj ebitda beat
estim reflect y/i margin expans rais guidanc includ anticip
wind-down transform certain busi anticip revenu adj ebitda
adj ep guid increas reflect combin
mortgag market benefit perhap clear less anticip low-margin revenu loss transform
maintain outperform attract yield pt
sign sale momentum encourag
report mix result revenu grew y/i vs our/street estim adjust
ep beat our/street estim includ lower expect tax rate import
quarterli net recur sale improv driven invest manag pb reflect disclos
result convers delay plan convers timelin swp like due intern issu
prioriti manag continu suggest swp sale activ remain robust hope sale result turn
corner remain optimist regard swp sale momentum pb long-term profit trajectori note
supplement note
 finish year solid note provid encourag outlook
visa report solid result net revenu grew y/i cc ep beat our/street
estim grew y/i despit fx drag intra-quart volum growth thru octob solid
continu dd transact growth stabl us volum growth modestli improv cross-bord volum growth acceler
importantli provid healthi outlook reflect low double-digit cc revenu growth mid-teen
organ cc ep growth adjust base combin fx/m drag encouragingli
renew total volum base anticip renew increment maintain outperform
rate pt
oppenheim cloud innov summit novemb san franciscofocu lead disrupt leverag ai
blockchain fintech
cloud updateamzn report slow cloud growth larg base
cloud
follow broadband strength remain resili strong year nbc/ski tweak
broadband revenue grew strong net add vs estim arpu growth
trend continu would drive cabl margin bp per year addit expect strong
tailwind across board nbc driven olymp polit advertis new anim movi theme
park believ stock appear inexpens per share yield maintain price target
tweak estim slightli shown
report result guidanc consensu reiter outperform pt
report solid result consensu expect rais guidanc highlight includ beat-
and-rais quarter record net-new recur custom add record ebitda margin strong gener
encourag analyt commentari manag also provid earli look guidanc revenu growth
ebitda growth consensu est could act anchor long-term investor balanc intern
remain somewhat elus busi could becom good growth driver futur bottom line anoth good-
and-consist quarter deliv welcom softwar space current volatil anticip
good result futur busi march toward long-term ebitda margin target support
valuat reiter outperform rais pt
headwind near-term upcom catalyst
junip report mix result solid cloud/enterpris growth demand security/switch product offset
soft servic provid rout trend cautiou head due persist sp weak slow
enterpris pipelin macro concern nonetheless optimist long-term see enterpris trend improv
new hire ramp earli junip product refresh mx line-card qfx/ptx mist wlan could
expand junip presenc new use case hyperscal leaf-spin campu multipl product catalyst bearish
investor sentiment increment ad share buy-back asr see favor risk/
reward scenario maintain outperform trim price target
analyt collabor infrastructur softwar
get closer inflect point
citrix report solid september-quart result above-consensu revenue/ep guidanc
expect repres trough point revenu growth margin expans transit subscript matur
compani provid detail insight workspac evolut product platform network gradual
transit as-a-servic busi line set financi benchmark reflect rise seat penetr
broader adopt platform acceler growth/margin metric citrix long-term financi target seem
increasingli achiev base current pace subscription/saa traction nonetheless believ share
appropri price tweak estim results/guid maintain perform
report sales/ep well street guid sales/ep
ahead consensu reacceler dcg despit challeng macro increasingli competit
environ well receiv lead stock higher near term move forward capit intens like rise
acceler process node conversionsattempt move back year cadenc maintain
competit vs core ccg/dcg busi increas invest level like put downward pressur
vs caus eps/fcf/sharehold return declin peak level structur
growth capit alloc effect theme within semi group see better exampl elsewher
creat million fund use beyond phone reuter
hisilicon chip power nearli huawei handset shipment say digitim research digitim
india lpwan network expand meet smart citi iot demand ee time
consist preview compstore slightli street weaker industri trend period
fulli account sell-sid estim view margin manag surprisingli well ebitda beat
difficult compstore lap rearview comp trend improv octob believ overal setup becom
favor particularli ebitda lack earn downsid base analysi
appoint former ceo amena ceo maintain outperform
search announc appoint michael spano presid ceo spano serv ceo
asia middl east north africa amena appoint repres spanoss first role leisur sector
first stint public-compani ceo settl would eager hear plan stimul compani
organ growth steadi intern expans would also eager hear view compani capit return
polici dividend remain modestli cover maintain outperform
industri headwind particularli apac weigh near-term outlook
report adj ep vs miss driven broad-bas revenu under-perform apac
core sale region materi weaker across segment lower expect industri margin given
weaker anticip ytd revenu continu demand soft lower organ sale guidanc
flat y/i vs lsd initi outlook msd overal find top-lin headwind unsurpris given end-market
exposur automot leverag industri segment signific intern presenc through-the-
cycl invest philosophi like continu pressur near-term earn potenti share expect compani
well posit leverag eventu upturn demand
report busi close two acquisit establish near-term close timet divestitur other
expect near term gener opportunist issu bond attract rate organ profil
track line nss segment msd lower track flat/- vs prior process
msd vs lsd transcor nyc congest toll project contract includ
instal roll-out plu six year operations/mainten sale ttm /ebitda
remain consist
sustain growth resourc optim
first look result
re-affirmed adj guidanc post adj ebitda/ep consensu in-lin revenu wast tip
fee revenu grew organ price volum profil wast organ plan mainten
spend increas y/i higher volum like reflect improv throughput tip fee plant manag made chang
mainten outlook increment commod price soft inventori time drove metal
metal outlook revis estim low end prior guidanc rang reiter
outlook energi revenu look updat key strateg growth initi includ uk wte pipelin
tap well earli indic earn call et tomorrow
first look oil product strong expens profil drive earn
southwestern continu execut control amid dismal natur ga price environ compani pivot
liquid continu liquid repres total product oil surprisingli high oil product
mb/d drove earn beat buttress unit expens came expect hope get quantif friday
call much factor compress drive higher northeast appalachia product also hope get color
updat type curv southwest appalachia given strong oil growth seen amid strong oper result
net debt continu inch higher nudg leverag expect share modestli outperform
friday given strong oil growth see noth releas chang cautiou view southwestern outlook
amid weak natur ga price expect persist
sustain growth resourc optim
revis preliminari guidanc expect
pre-announc downsid earn guidanc detail full report releas
mix toller issu price adjust compani indic lithium busi deliv ebitda margin
account non-cash inventori charg ebitda margin would note lithium price
remain flat slightli y/i given strength contract expect recogn increment ebitda
push due delay shipment compani also indic expect margin drag lithium
busi ebitda ramp new capac account on-going price pressur expect compani
provid signific addit detail novemb confer call share pressur call
sustain growth resourc optim
earn commentari point sever cross wind
post disappoint result project sale push compani maintain top-
bottom-lin guidanc increas gm reduc opex modestli note potenti risk ep given
project monet time due typhoon relat issu japan manag also plan wait earli provid
guidanc given uncertainti around seri capac retir timing/logist strateg evalu busi
segment adjust number reflect result updat guidanc remain sidelin due
believ challeng upsid expect lt earn power increas competit difficult cash flow environ
mani modul custom us
ep y/i consensu landstar origin guidanc landstar
indic would achiev low end ep guidanc primarili due
sever vehicular accid well overal market condit total revenu decreas y/i truck volume/
revenu per load decreas y/i vs guidanc low-singl digit decrease/low double-digit decreas respect
partli weaker condit manufactur sector number load via truck revenu per load total revenu
adjust ep guid high-singl digit high-singl digit y/i
respect modifi follow result guidanc
report ep vs our/consensu share continu struggl part like due polit
overhang yet say small piec puzzl like credit increment cecl impact nim
fall pressur roa/rotc chang growth valu anticip buy-back announc
find like investor given progress seen financi capit alloc
expens manag two pillar like within manag clearest control without buy-back given
cecl commentari ep yoy growth acceler reliant effici gain matur busi remain cautiou
dec cloud summit aw inventla vega nv
may biotech summit featur chemistri life process institutechicago
